StageZero Life Sciences Ltd
TSX:SZLS

Watchlist Manager
StageZero Life Sciences Ltd Logo
StageZero Life Sciences Ltd
TSX:SZLS
Watchlist
Price: 0.04 CAD Market Closed
Market Cap: 4.9m CAD

Net Margin
StageZero Life Sciences Ltd

-101.7%
Current
-188%
Average
-6.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-101.7%
=
Net Income
-1.4m
/
Revenue
1.4m

Net Margin Across Competitors

No Stocks Found

StageZero Life Sciences Ltd
Glance View

Market Cap
4.9m CAD
Industry
Biotechnology

StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. The company is headquartered in Richmond Hill, Ontario and currently employs 80 full-time employees. The firm has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. The firm offers ColonSentry product, which is a blood test to determine an individual’s current risk for having colorectal cancer. The company offers Aristotle, a mRNA-based multi-cancer detection panel for simultaneously screening of various cancers from a single sample of blood. In addition, the Company offers various COVID-19 tests, including polymerase chain reaction (PCR) tests and antibody tests. Its PCR tests can detect COVID-19 nucleic acid from patient nasopharyngeal swab specimens or saliva and are used to diagnose an active COVID-19 infection.

SZLS Intrinsic Value
0.05 CAD
Undervaluation 15%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-101.7%
=
Net Income
-1.4m
/
Revenue
1.4m
What is the Net Margin of StageZero Life Sciences Ltd?

Based on StageZero Life Sciences Ltd's most recent financial statements, the company has Net Margin of -101.7%.

Back to Top